An SEC Comment Challenge: Find the Non-GAAP Measure Issue – Post Four

Oct 06 10-Q — 8-K — Blog Post — Non-GAAP

An SEC Comment Challenge: Find the Non-GAAP Measure Issue – Post Three

Oct 01 10-Q — Blog Post — Non-GAAP

LIBOR Transition: Implications for the Valuation of Floating Rate Instruments

Oct 01 Article — Valuation

The Valuation of Distressed Assets: Impact of COVID-19

Oct 01 Article — COVID-19 — Valuation

An SEC Comment Challenge: Find the Non-GAAP Measure Issue – Post Two

Sep 29 10-Q — 8-K — Blog Post — Non-GAAP

An SEC Comment Challenge: Find the Non-GAAP Measure Issue – Post One

Sep 25 10-Q — 8-K — Blog Post — COVID-19 — Non-GAAP — SEC Comment Letter

An SEC Comment Challenge: Find the Non-GAAP Measure Issue – Post One

Sep 24 10-Q — 8-K — Blog Post — Non-GAAP

Fending Off Bankruptcy Preference Claims During a Pandemic

Sep 24 Article — COVID-19

A Big Day in SEC Rulemaking

Sep 24 Blog Post — SEC — Whistleblower

And the Beat Goes On – The Whistleblower Song

Sep 21 Blog Post — SEC — Whistleblower

A Primer for Post-COVID Equity Award Modifications

Aug 31 Blog Post — COVID-19

COVID-19 and Hospital and Physician Practices: The Impact on M&A Activity and a Valuation Outlook

Aug 21 Article — COVID-19 — Sponsor Resources — Valuation

A Primer for Post-COVID Equity Award Modifications

Aug 21 Article — Compensation — COVID-19 — Sponsor Resources

The SEC’s Updated RegFlex Agenda

Jul 30 COVID-19 — Disclosure Effectiveness — Proxy — SEC

A New Format and Approach for Inspection Reports

Jul 28 Blog Post — PCAOB

A Few Last Minute COVID-19 Disclosure Considerations

Jul 27 10-Q — Blog Post — COVID-19 — MD&A

COVID-19 Uncertainty in Earnings Releases

Jul 23 10-Q — Blog Post — COVID-19 — Disclosure Effectiveness

SEC Updates to COVID-19 Guidance

Jul 13 10-Q — Blog Post — COVID-19 — Disclosure Effectiveness

First Quarter COVID-19 Disclosure Examples – Part Five - Clorox

Jun 30 10-Q — Blog Post — COVID-19 — Disclosure Effectiveness

First Quarter COVID-19 Disclosure Examples – Part Four

Jun 24 10-Q — Blog Post — COVID-19 — Disclosure Effectiveness

CorpFin Issues Disclosure Guidance Topic 9A - Coronavirus (COVID-19) — Disclosure Considerations Regarding Operations, Liquidity, and Capital Resources

Jun 23 COVID-19 — Disclosure Effectiveness — Financial Reporting

Steve Explains Accounting Memes: Jim Halpert and the Sorting Hat

Jun 16 Podcast

XBRL Xplained: Pranav Ghai of Calcbench

Jun 15 Podcast — XBRL

First Quarter COVID-19 Disclosure Examples – Part Three

Jun 15 Blog Post — COVID-19 — Disclosure Effectiveness

Reasonably Equivalent Value: What Distressed-Asset Buyers Should Know

Jun 08 Article — COVID-19

COVID-19 and Accounting for Loan Modifications

Jun 05 Article — COVID-19

Recommendations for Fair Value Measurement Amid Market Disruption

Jun 04 COVID-19 — Valuation — White Paper

Transatlantic Panic: The State of Finance Today in the EU

Jun 01 COVID-19 — Podcast

The SEC Marches Forward with its Disclosure Effectiveness Program

May 26 Blog Post — Disclosure Effectiveness — SEC

The (Mario) Party’s Over: Nintendo’s Data Breach

May 26 Podcast — Technology, Software, Vendors

The Importance of Equity Compensation Accounting During Uncertain Times

May 21 Blog Post — Compensation — COVID-19

First Quarter COVID-19 Disclosure Examples – Part Two

May 19 10-Q — Blog Post — COVID-19

Hitting the Books with Prof. Bill Dilla: Part Two

May 14 Podcast — Q&A

Hitting the Books with Prof. Bill Dilla: Part One

May 06 Podcast — Q&A

Eerie Accountancy: The Whistling Weakness

Apr 28 Lease Accounting Standard — Material Weakness — Podcast

SEC and PCAOB Issue Statement About Emerging Market Investments

Apr 24 Blog Post — Disclosure Effectiveness — PCAOB — SEC